This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Reven Holdings, lamenting devalued IP, seeks review of partially denied request to lift asset freeze

( August 9, 2024, 10:10 GMT | Official Statement) -- MLex Summary: Two appeals by Reven Holdings and others of adverse rulings in a lawsuit by the US Securities and Exchange Commission over efforts to mislead investors were consolidated Friday at the US Court of Appeals for the Tenth Circuit. In the first, filed in May, Reven challenges an asset freeze entered in March; the second, filed last week, involves the biotechnology company’s thwarted bid for a lift of the same asset freeze in order to pay patent maintenance fees, explore licensing opportunities and conduct clinical trials on their drug Rejuveinix. US Judge Daniel D. Domenico of the District of Colorado granted the request in part but denied Reven “free reign” over assets based on plans he called “vague.” Domenico additionally refused to stay the freeze during Reven’s appeal.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections